The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AnaptysBio, Inc(NASDAQ:ANAB) 
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. The company's products include Imsidolimab, an IL-36R antibody that inhibits the interleukin-36 receptor for the treatment of various derma...
Website: http://www.anaptysbio.com
Founded: 2005
Full Time Employees: 89
Sector: Healthcare
Industry: Biotechnology
AnaptysBio Days Payable Outstanding ttm (DPO)
AnaptysBio Days Receivable Outstanding ttm (DSO)
AnaptysBio Days Inventory Outstanding ttm (DIO)
AnaptysBio Op Cashflow Per Share ttm
AnaptysBio Free Cashflow Per Share ttm
AnaptysBio Cash Per Share ttm
AnaptysBio P/S ratio ttm
AnaptysBio (GAAP) P/E ratio ttm
AnaptysBio P/B ratio ttm
No extra charts and metrics for this ticker.